BAX Jan 2025 37.500 put
| Previous close | 5.12 |
| Open | 5.12 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 37.50 |
| Expiry date | 2025-01-17 |
| Day's range | 5.12 - 5.12 |
| Contract range | N/A |
| Volume | |
| Open interest | 263 |
Business WireNew Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
DEERFIELD, Ill., May 29, 2024--Baxter International Inc. (NYSE:BAX), a global innovator in kidney care and vital organ support, today announced new data showing expanded hemodialysis, known as HDx therapy, enabled by Theranova dialyzer, was associated with an approximately 25% lower all-cause mortality risk for up to four years when compared to high-flux hemodialysis (HF HD). The study, "Survival of expanded hemodialysis and high-flux hemodialysis patients in Colombia: a cohort study," was prese
ZacksReasons to Retain Baxter International (BAX) in Your Portfolio Now
Baxter International's (BAX) robust growth across all geographies, along with transformational initiatives, boosts confidence. However, pandemic-related disruption continues to hurt sales.
Simply Wall St.Don't Buy Baxter International Inc. (NYSE:BAX) For Its Next Dividend Without Doing These Checks
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Baxter...
